medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2011; 10 (3)


Anatomical cardiac alterations in liver cirrhosis: An autopsy study

Ortiz-Olvera NX, Castellanos-Pallares G, Gómez-Jiménez LM, Cabrera-Muñoz ML, Méndez-Navarro J, Morán-Villota S, Dehesa-Violante M

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 321-326
Archivo PDF: 47.43 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451-9.

  2. Ruiz-del-Árbol L, Monescillo A, Arocena C, Valer P, Ginés P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439-47.

  3. Bethke BA, Schubert GE. Primary hepatic cancer and liver cirrhosis. Autopsy study covering fifty years. Hepatogastroenterology 1984; 31: 211-4.

  4. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec´s cirrhosis. J Clin Invest 1953; 32: 1025-33.

  5. Møller S, Henriksen JH. The systemic circulation in cirrhosis. In: Ginés P, Arroyo V, Podes J, Schrier RW (eds.). Ascites and renal dysfunction in liver disease. 2nd. Ed. Malden: Blackwell Science; 2005, p. 139-55.

  6. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009; 3: 294-304.

  7. Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassell BW, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56: 539-49.

  8. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 179-90.

  9. Al-Hamoudi WK. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol 2010; 16: 145-53.

  10. Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred and eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med 1958; 102: 405-13.

  11. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31: 395-414.

  12. Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 2006; 22: 209-14.

  13. Pérez-Tamayo R. Las causas de muerte en México. En: Pérez T (ed.). Introducción a la Patología. 1a. Ed. México: Edit Melo, S.A.; 1976, p. 389-97.

  14. Hoefs JC. Characteristics of ascites. In: Arroyo V, Ginés P, Podes J, Schrier RW (eds). Ascites and renal dysfunction in liver disease. 1a. Ed. Malden: Blackwell Science; 1999, p. 14-35.

  15. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-3.

  16. Hall EM, Olsen AY, Davis FE. Portal Cirrhosis: Clinical and pathological review of 782 cases from 16,600 necropsies. Am J Pathol 1953; 29: 993-1027.

  17. Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med 1989; 151: 530-5.

  18. Spatt SD, Rosenblatt P. The incidence of hypertension in portal cirrhosis: A study of 80 necropsied cases of portal cirrhosis. Ann Intern Med 1949; 31: 479-83.

  19. Torregrosa M, Aguadé S, Dos L, Segura R, González A, Evangelista A, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005; 42: 68-74.




2020     |     www.medigraphic.com